Cover Image
Market Research Report

GCC Generic Injectables Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024

Published by IMARC Services Private Limited Product code 693007
Published Content info 95 Pages
Delivery time: 2-3 business days
Price
Back to Top
GCC Generic Injectables Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024
Published: February 11, 2019 Content info: 95 Pages
Description

The GCC generic injectables market was worth US$ 438 Million in 2018. The market is further projected to reach a value of US$ 865 Million by 2024, exhibiting a CAGR of 12% over the forecast period. Generic injectables are equivalents of brand-name injectables with respect to quality, dosage, route of administration, performance, strength and intended use. They are used for treating a wide array of life-threatening and chronic diseases including diabetes, cancer, cardiovascular diseases, rheumatoid arthritis, respiratory diseases, osteoporosis, etc. In the GCC region, a rise in the prevalence of various lifestyle diseases has catalysed the uptake of generic injectables. The lower cost of these drugs compared to their branded equivalents further helps in providing substantial savings for the patients and healthcare providers.

GCC Generic Injectables Market Drivers/Constraints:

  • An increase in the emigrant population along with a rise in both acute and chronic diseases has challenged the capability of the existing healthcare resources in the region. The consequent surge in the overall healthcare costs has boosted the demand for generic injectables.
  • Upcoming patent expiry of a number of blockbuster drugs prescribed in key therapeutic areas is expected to help in expanding the product portfolio of generic injectable manufacturers.
  • The total number of manufacturers in the generic injectables market is limited as compared to oral generics. This results in lower price erosion and significantly higher margins.
  • Some of the other factors driving the generic injectables market in the region include a rising ageing population, development of the private healthcare market, improving standards of living, better awareness of health issues, etc.

Regional Insights:

  • Region-wise, Saudi Arabia represents the leading market, holding the largest market share. Other major regions include the UAE, Kuwait, Qatar, Oman and Bahrain.

Therapeutic Area Insights:

  • Based on the therapeutic area, oncology holds the largest market share. A rise in the number of cancer diagnoses coupled with improved access to treatment is currently driving the growth of this segment. Other major segments include anaesthesia, anti-infectives, cardiovascular, parenteral nutrition and others.

Distribution Channel Insights:

  • The market has also been divided on the basis of distribution channel as hospitals, clinics and retail pharmacy stores. Generic injectables are majorly distributed through hospitals.

Container Types:

  • On the basis of container type, the market has been segmented into vials, prefilled syringes, ampoules, premix and others. Currently, vials represent the major container type, accounting for the majority of the total market share.

Competitive Landscape:

  • The competitive landscape of the GCC generic injectables market along with the profiles of key players has also been analysed in the report.
  • This report provides a deep insight into the GCC generic injectables industry covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc. The report also provides a comprehensive analysis for setting up a generic injectables manufacturing plant. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the generic injectables industry in any manner.

Key Questions Answered in This Report:

  • How has the GCC generic injectables market performed so far and how will it perform in the coming years?
  • What are the key regional markets in the GCC generic injectables industry?
  • What are the key therapeutic areas in the GCC generic injectables industry?
  • What are the major distribution channels in the GCC generic injectables industry?
  • What are the major container types in the GCC generic injectables industry?
  • What are the various stages in the value chain of the GCC generic injectables industry?
  • What are the key driving factors and challenges in the GCC generic injectables industry?
  • What is the structure of the GCC generic injectables industry and who are the key players?
  • What is the degree of competition in the GCC generic injectables industry?
  • What are the profit margins in the GCC generic injectables industry?
  • What are the key requirements for setting up a generic injectables manufacturing plant?
  • How are generic injectables manufactured?
  • What are the various unit operations involved in a generic injectables manufacturing plant?
  • What is the total size of land required for setting up a generic injectables manufacturing plant?
  • What are the machinery requirements for setting up a generic injectables manufacturing plant?
  • What are the raw material requirements for setting up a generic injectables manufacturing plant?
  • What are the packaging requirements for generic injectables?
  • What are the transportation requirements for generic injectables?
  • What are the utility requirements for setting up a generic injectables manufacturing plant?
  • What are the manpower requirements for setting up a generic injectables manufacturing plant?
  • What are the capital costs for setting up a generic injectables manufacturing plant?
Table of Contents
Product Code: SR1018G56_Report

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 GCC Generic Injectables Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Market Breakup by Region
  • 5.4 Market Breakup by Therapeutic Area
  • 5.5 Market Breakup by Container Type
  • 5.6 Market Breakup by Distribution Channel
  • 5.7 Market Forecast
  • 5.8 SWOT Analysis
    • 5.8.1 Overview
    • 5.8.2 Strengths
    • 5.8.3 Weaknesses
    • 5.8.4 Opportunities
    • 5.8.5 Threats
  • 5.9 Value Chain Analysis
    • 5.9.1 Research and Development
    • 5.9.2 Manufacturing
    • 5.9.3 Marketing and Distribution
  • 5.10 Porter's Five Forces Analysis
    • 5.10.1 Overview
    • 5.10.2 Bargaining Power of Supplier
    • 5.10.3 Bargaining Power of Buyers
    • 5.10.4 Degree of Competition
    • 5.10.5 Threat of New Entrants
    • 5.10.6 Threat of Substitutes
  • 5.11 Price Analysis
    • 5.11.1 Key Price Indicators
    • 5.11.2 Price Structure
    • 5.11.3 Margin Analysis
  • 5.12 Key Market Drivers and Success Factors

6 Market Performance by Key Regions

  • 6.1 Saudi Arabia
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 UAE
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Kuwait
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Qatar
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Oman
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Bahrain
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Performance by Container Type

  • 7.1 Vials
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Prefilled Syringes
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Ampoules
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Premix
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Performance by Therapeutic Area

  • 8.1 Oncology
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Anaesthesia
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Anti-infectives
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Cardiovascular
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Parenteral Nutrition
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Performance by Distribution Channel

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Retail Pharmacy Stores
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Competitive Landscape

  • 10.1 Competitive Structure
  • 10.2 Key Players

11 Generic Injectable Manufacturing Process

  • 11.1 Product Overview
  • 11.2 Detailed Process Flow
  • 11.3 Various Types of Unit Operations Involved
  • 11.4 Mass Balance and Raw Material Requirements

12 Project Details, Requirements and Costs Involved

  • 12.1 Land, Location and Site Development
  • 12.2 Construction Requirements
  • 12.3 Machinery Requirements
  • 12.4 Machinery Pictures
  • 12.5 Raw Material Requirements
  • 12.6 Raw Material and Final Product Pictures
  • 12.7 Packaging Requirements
  • 12.8 Transportation Requirements
  • 12.9 Utility Requirements
  • 12.10 Manpower Requirements
  • 12.11 Other Capital Investments

13 Key Player Profiles

List of Figures

  • Figure 1: GCC: Generic Injectables Market: Major Drivers and Challenges
  • Figure 2: GCC: Generic Injectables Market: Sales Value (in Million US$), 2011 - 2018
  • Figure 3: GCC: Generic Injectables Market: Breakup by Region (in %), 2018
  • Figure 4: GCC: Generic Injectables Market: Breakup by Therapeutic Area (in %), 2018
  • Figure 5: GCC: Generic Injectables Market: Breakup by Container Type (in %), 2018
  • Figure 6: GCC: Generic Injectables Market: Breakup by Distribution Channel (in %), 2018
  • Figure 7: GCC: Generic Injectables Market Forecast: Sales Value (in Million US$), 2019 - 2024
  • Figure 8: GCC: Generic Injectables Industry: SWOT Analysis
  • Figure 9: GCC: Generic Injectables Market: Value Chain Analysis
  • Figure 10: GCC: Generic Injectables Industry: Porter's Five Forces Analysis
  • Figure 11: Saudi Arabia: Generic Injectables Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 12: Saudi Arabia: Generic Injectables Market Forecast: Sales Value (in Million US$), 2019 - 2024
  • Figure 13: UAE: Generic Injectables Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 14: UAE: Generic Injectables Market Forecast: Sales Value (in Million US$), 2019 - 2024
  • Figure 15: Kuwait: Generic Injectables Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 16: Kuwait: Generic Injectables Market Forecast: Sales Value (in Million US$), 2019 - 2024
  • Figure 17: Qatar: Generic Injectables Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 18: Qatar: Generic Injectables Market Forecast: Sales Value (in Million US$), 2019 - 2024
  • Figure 19: Oman: Generic Injectables Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 20: Oman: Generic Injectables Market Forecast: Sales Value (in Million US$), 2019 - 2024
  • Figure 21: Bahrain: Generic Injectables Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 22: Bahrain: Generic Injectables Market Forecast: Sales Value (in Million US$), 2019 - 2024
  • Figure 23: GCC: Generic Injectables (in Vials) Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 24: GCC: Generic Injectables (in Vials) Market Forecast: Sales Value (in Million US$), 2019 - 2024
  • Figure 25: GCC: Generic Injectables (in Prefilled Syringes) Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 26: GCC: Generic Injectables (in Prefilled Syringes) Market Forecast: Sales Value (in Million US$), 2019 - 2024
  • Figure 27: GCC: Generic Injectables (in Ampoules) Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 28: GCC: Generic Injectables (in Ampoules) Market Forecast: Sales Value (in Million US$), 2019 - 2024
  • Figure 29: GCC: Generic Injectables (in Premix) Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 30: GCC: Generic Injectables (in Premix) Market Forecast: Sales Value (in Million US$), 2019 - 2024
  • Figure 31: GCC: Generic Injectables (in Other Container Types) Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 32: GCC: Generic Injectables (in Other Container Types) Market Forecast: Sales Value (in Million US$), 2019 - 2024
  • Figure 33: GCC: Generic Injectables Market (Oncology): Sales Value (in Million US$), 2011 & 2018
  • Figure 34: GCC: Generic Injectables Market (Oncology) Forecast: Sales Value (in Million US$), 2019 - 2024
  • Figure 35: GCC: Generic Injectables Market (Anaesthesia): Sales Value (in Million US$), 2011 & 2018
  • Figure 36: GCC: Generic Injectables Market (Anaesthesia) Forecast: Sales Value (in Million US$), 2019 - 2024
  • Figure 37: GCC: Generic Injectables Market (Anti-infectives): Sales Value (in Million US$), 2011 & 2018
  • Figure 38: GCC: Generic Injectables Market (Anti-infectives) Forecast: Sales Value (in Million US$), 2019 - 2024
  • Figure 39: GCC: Generic Injectables Market (Cardiovascular): Sales Value (in Million US$), 2011 & 2018
  • Figure 40: GCC: Generic Injectables Market Forecast (Cardiovascular): Sales Value (in Million US$), 2019 - 2024
  • Figure 41: GCC: Generic Injectables Market (Parenteral Nutrition): Sales Value (in Million US$), 2011 & 2018
  • Figure 42: GCC: Generic Injectables Market Forecast (Parenteral Nutrition): Sales Value (in Million US$), 2019 - 2024
  • Figure 43: GCC: Other Generic Injectables Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 44: GCC: Other Generic Injectables Market Forecast: Sales Value (in Million US$), 2019 - 2024
  • Figure 45: GCC: Generic Injectables Market: Sales through Hospitals (in Million US$), 2011 & 2018
  • Figure 46: GCC: Generic Injectables Market Forecast: Sales through Hospitals (in Million US$), 2019 - 2024
  • Figure 47: GCC: Generic Injectables Market: Sales through Clinics (in Million US$), 2011 & 2018
  • Figure 48: GCC: Generic Injectables Market Forecast: Sales through Clinics (in Million US$), 2019 - 2024
  • Figure 49: GCC: Generic Injectables Market: Sales through Retail Pharmacy Stores (in Million US$), 2011 & 2018
  • Figure 50: GCC: Generic Injectables Market Forecast: Sales through Retail Pharmacy Stores (in Million US$), 2019 - 2024
  • Figure 51: Generic Injectable Manufacturing: Detailed Process Flow
  • Figure 52: Generic Injectable Manufacturing Process: Conversion Rate of Feedstocks
  • Figure 53: Generic Oncology Drug Manufacturing Plant: Tertiary Packaging
  • Figure 54: Generic Injectable Manufacturing Process: Breakup of Capital Costs (in %)
  • Figure 55: Generic Injectables Industry: Breakup of Profit Margins at Various Level of the Value Chain

List of Tables

  • Table 1: GCC: Generic Injectables Market: Key Industry Highlights, 2018 and 2024
  • Table 2: GCC: Generic Injectables Market Forecast: Breakup by Region (in Million US$), 2019 - 2024
  • Table 3: GCC: Generic Injectables Market Forecast: Breakup by Container Type (in Million US$), 2019 - 2024
  • Table 4: GCC: Generic Injectables Market Forecast: Breakup by Therapeutic Area (in Million US$), 2019-2024
  • Table 5: GCC: Generic Injectables Market Forecast: Breakup by Distribution Channel (in Million US$), 2019 - 2024
  • Table 6: GCC: Generic Injectables Industry: Competitive Structure
  • Table 7: GCC: Generic Injectables Market: Key Players
Back to Top